Improvement of Pulmonary Function by Oral Treatment with a VLA-4 Antagonist in a Mouse Asthmatic Model
Gensuke Takayama(Daiichi-Sankyo (Japan)), Tohru Takashi(Daiichi-Sankyo (Japan)), Tomoe Taira(Daiichi-Sankyo (Japan)), Keiko Matsumoto(Kagawa University), Mika Yokoyama(Daiichi-Sankyo (Japan)), Yutaka Iigo, Misato Aonuma(Daiichi-Sankyo (Japan))
Cited by 3
Related Papers
Detection of bone metastases in non‐small cell lung cancer patients: Comparison of whole‐body diffusion‐weighted imaging (DWI), whole‐body MR imaging without and with DWI, whole‐body FDG‐PET/CT, and bone scintigraphy
|Journal of Magnetic Resonance Imaging|2009|183
Differentiation of Malignant and Benign Pulmonary Nodules with Quantitative First-Pass 320–Detector Row Perfusion CT versus FDG PET/CT
|Radiology|2011|129
Diffusion-Weighted MRI Versus 18F-FDG PET/CT: Performance as Predictors of Tumor Treatment Response and Patient Survival in Patients With Non–Small Cell Lung Cancer Receiving Chemoradiotherapy
|American Journal of Roentgenology|2011|128
Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas
|European Radiology|2009|75
T2<sup>*</sup> Measurements of 3-T MRI With Ultrashort TEs: Capabilities of Pulmonary Function Assessment and Clinical Stage Classification in Smokers
|American Journal of Roentgenology|2011|69